3.640USD-4.84%Mkt Cap: 290.30M USDP/E: 17.36Last update: 2026-06-01
Niagen Bioscience, Inc. operates as a bioscience company engages in developing healthy aging products. The company operates through Consumer products; Ingredients; and Pharmaceutical Segments. It provides finished dietar…
Industry Peers
BiotechnologyIndicators:|
Key Statistics
Company
Market Cap290.30M USD
Enterprise Value244.25M USD
Revenue (TTM)130.42M USD
Gross Profit83.19M USD
Net Income (TTM)17.38M USD
Revenue/Share1.636 USD
Last Price3.640 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees117
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)17.36
P/E (Forward)12.06
PEG—
EV/EBITDA20.39
EV/Revenue1.87
P/S2.36
P/B3.73
EPS (TTM)0.21
EPS (Forward)0.32
52W Range
3.5701% of range14.69
52W High14.69 USD
52W Low3.570 USD
Profitability
Gross Margin64.28%
Oper. Margin5.01%
EBITDA Margin9.19%
Profit Margin13.43%
ROE22.71%
ROA16.34%
Growth
Revenue Growth3.30%
Earnings Growth16.70%
Cash Flow & Leverage
Operating CF13.50M USD
CapEx (TTM)292.00K USD
FCF Margin-1.43%
FCF Yield-0.64%
Net Debt-63.82M USD
Net Debt/EBITDA-5.33
Balance Sheet
Debt/Equity0.04
Current Ratio4.61
Quick Ratio3.48
Book Value/Sh1.034 USD
Cash/Share0.8320 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:3
Split DateApr 13, 2016
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)12.60 USD
Target Range10.00 USD – 18.00 USD
# Analysts5
Ownership
Shares Out.79.64M
Float59.57M
Insiders29.25%
Institutions47.34%
Short Interest
Short Ratio5.1d
Short % Float9.62%
Short % Out.6.27%
Shares Short4.99M
Short (prev mo.)5.45M
Technical
SMA 504.415 (-17.6%)
SMA 2006.461 (-43.7%)
Beta2.17
S&P 52W Chg27.94%
Avg Vol (30d)934.55K
Avg Vol (10d)939.41K
Technical Indicators
RSI (14)40.1
MACD-0.2172
MACD Signal-0.2343
MACD Hist.+0.0171
BB Upper4.963 USD
BB Middle4.052 USD
BB Lower3.142 USD
BB Width44.96%
ATR (14)0.2212 USD
Vol Ratio (20d)1.14x